Palvella Therapeutics Inc... (PVLA)
NASDAQ: PVLA
· Real-Time Price · USD
25.25
-1.17 (-4.43%)
At close: Jun 13, 2025, 3:59 PM
23.80
-5.74%
After-hours: Jun 13, 2025, 05:18 PM EDT
-4.43% (1D)
| Bid | 19.6 |
| Market Cap | 279.16M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.25M |
| EPS (ttm) | -2.05 |
| PE Ratio (ttm) | -12.32 |
| Forward PE | -7.78 |
| Analyst | Buy |
| Ask | 28 |
| Volume | 221,703 |
| Avg. Volume (20D) | 82,012 |
| Open | 26.41 |
| Previous Close | 26.42 |
| Day's Range | 24.70 - 26.50 |
| 52-Week Range | 6.20 - 29.27 |
| Beta | -0.10 |
About PVLA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PVLA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PVLA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-15.72%
Palvella Therapeutics shares are trading lower on ...
Unlock content with
Pro Subscription
4 months ago
+6.26%
Palvella Therapeutics shares are trading higher after TD Cowen initiated coverage on the stock with a Buy rating and announced a price target of $44.